Table 1.
Case | Age | Sex | BMI (kg/m2) | Vaccine | Dose | Onset | Incorrect Technique | Range of Motion | Finding | Medication | Return to Normal Activities after Initial Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 52 | M | 24.22 | Sinovac | 1st | Within 72 h | Wrong direction | Limited | Subacromial bursitis | Antibiotic + oral celecoxib | 14 days |
2 | 51 | F | 23.91 | AstraZeneca | 1st | 3 h | Too high | Limited | Subacromial-subcoracoid bursitis and supraspinatous tear | Oral prednisolone | 3 days |
3 | 66 | M | 24.53 | AstraZeneca | 2nd | Immediately | Wrong direction | Limited | - | Oral prednisolone | 7 days |
4 | 71 | M | 29.26 | AstraZeneca | 2nd | 24 h | Too high | Full but painful | Thin subacromial-subcoracoid bursitis and low-grade partial tear of supraspinatous tendon | Oral prednisolone | 14 days |
5 | 68 | F | 23.73 | AstraZeneca | 2nd | Within 24 h | Wrong direction | Full but painful | Thin subdeltoid bursal fluid and partial thickness tear of subscapularis tendon | Oral prednisolone | 7 days |
6 | 64 | M | 26.94 | AstraZeneca | 1st | Within 48 h | Wrong direction | Limited | Tenosynovitis of long head of biceps and low-grade partial tear of subscapularis tendon | Combined oral prednisolone and TA injection | 7 days |
7 | 64 | F | 23.11 | AstraZeneca | 1st | Immediately | Too high | Limited | Calcific tendinopathy of supraspinatous tendon | Oral prednisolone | 5 days |